Paris - Delayed Quote EUR

Amplitude Surgical SA (AMPLI.PA)

Compare
3.2800
+0.0200
+(0.61%)
At close: 5:35:25 PM GMT+1
Loading Chart for AMPLI.PA
DELL
  • Previous Close 3.2600
  • Open 3.2600
  • Bid --
  • Ask --
  • Day's Range 3.2600 - 3.2800
  • 52 Week Range 2.7000 - 3.6600
  • Volume 611
  • Avg. Volume 1,199
  • Market Cap (intraday) 157.345M
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) 109.33
  • EPS (TTM) 0.0300
  • Earnings Date Mar 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company exports its products through a network of distributors and agents in approximately 30 countries. It serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. Amplitude Surgical SA is a subsidiary of Auroralux SAS.

www.amplitude-surgical.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: AMPLI.PA

View More

Performance Overview: AMPLI.PA

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMPLI.PA
3.80%
CAC 40
5.42%

1-Year Return

AMPLI.PA
4.09%
CAC 40
4.21%

3-Year Return

AMPLI.PA
53.27%
CAC 40
7.93%

5-Year Return

AMPLI.PA
97.59%
CAC 40
27.67%

Compare To: AMPLI.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMPLI.PA

View More

Valuation Measures

As of 1/16/2025
  • Market Cap

    156.39M

  • Enterprise Value

    246.41M

  • Trailing P/E

    102.45

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.48

  • Price/Book (mrq)

    1.63

  • Enterprise Value/Revenue

    2.32

  • Enterprise Value/EBITDA

    10.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.41%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    106M

  • Net Income Avi to Common (ttm)

    1.5M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AMPLI.PA

View More

People Also Watch